Resources for Researchers

NIAID offers many resources to support your research, including reagents, model organisms, and tissue samples, to name just a few. Use the filters under Filter Search Results to narrow your search, or simply enter specific search terms in the search field.

Showing results filtered by:
ClEAR ALL
Clinical
DAIDS (Division of AIDS)
Immune System
8 Results

ACTG Network Laboratory (ACTG NL)

The ACTG NL consists of Core Laboratory groups in immunology, pharmacology, virology and TB.

DAIDS Regulatory Support Center (RSC)

The RSC Public Website, run by the DAIDS Regulatory Support Center (RSC) contractor, has been used in the DAIDS community for over 10 years and is a primary platform to communicate updates to templates, process changes, and other information needed by the RSC research community.

DAIDS VAX004 Clinical Trial Specimens

Repository of specimens collected as part of the DAIDS VAX004 Clinical Trial.

HIV Vaccine Trials Network (HVTN): Ancillary/Exploratory Studies

The HVTN shares data and specimens collected in its studies with investigators who would like to use our materials to answer research questions related to vaccinology, immunology, or HIV/AIDS.

HIV Vaccine Trials Network (HVTN): Scholar Awards

HVTN provides structured mentorship and project funding to investigators working on HIV vaccines.

International Epidemiologic Database to Evaluate AIDS Data Exchange Standard (IeDEA DES)

A common data model for sharing observational HIV data has been developed by the International epidemiology Databases to Evaluate AIDS (IeDEA). The IeDEA DES is used by the seven operational regions of IeDEA to exchange data with each other for collaborative research studies.

NIH AIDS Reagent Program

The National Institutes of Health (NIH) AIDS Reagent Program provides critical research reagents and resources to the scientific community. The ARP acquires, develops, and produces state-of-the-art reagents and provides these reagents at no cost to qualified investigators throughout the world.

Resources to Evaluate New Technologies for Monitoring HIV-infected Patients

Current methods for monitoring HIV-infected patients on antiretroviral therapy are expensive and technologically complex, making it difficult for use in resource-limited countries around the world.